| Amgen Switzerland AG - Aranesp 500 Mikrogramm, Injektionslösung in Fertigspritze |
| 55725 | | 12 | | Aranesp 500 Mikrogramm | | Injektionslösung in Fertigspritze | | B03XA02 | | Darbepoetin Alfa | | 17.04.2003 | | |
|
| Composition |
| darbepoetinum alfa 500 µg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml, natrium 3.79 mg. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Darbepoetin Alfa | 500 µg/ml |
| | BAG: Active Agent | Dose |
|---|
| Darbepoetin Alfa | 0.5 mg |
| | | | Inactive agents |
|---|
| Disodium Phosphate | | Sodium Chloride | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 073 | syringe(s) | 1039.95 | 1147.40 | A | SL | No |
|
